Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
03/27/1997 | WO1997011188A1 Plants which synthesise a modified starch, process for the production thereof and modified starch |
03/27/1997 | WO1997011182A1 New adhesin from helicobacter pylori |
03/27/1997 | WO1997011178A1 Human growth hormone variants |
03/27/1997 | WO1997011163A1 Pskh-1 ribozymes and uses in disease treatment |
03/27/1997 | WO1997011162A1 Production and use of type 5 17beta-hydroxysteroid dehydrogenase |
03/27/1997 | WO1997011156A2 Laser cell purification system |
03/27/1997 | WO1997011094A1 Novel variants of green fluorescent protein, gfp |
03/27/1997 | WO1997010851A2 Nucleic acid delivery vehicle |
03/27/1997 | WO1997010850A1 Transcytosis vehicles and enhancers for drug delivery |
03/27/1997 | WO1997010837A1 Tumor rejection antigens presented by hla-b44 molecules, and uses thereof |
03/27/1997 | WO1997010796A2 MANIPULATION AND DETECTION OF PROTEIN PHOSPHATASE 2C - PP2Cα - EXPRESSION IN TUMOR CELLS FOR CANCER THERAPY, PREVENTION AND DETECTION |
03/27/1997 | WO1996040082A3 Apparatus and method for delivering a biologically active compound into a biological environment |
03/27/1997 | DE19547272C1 Expression system for anaerobic gene expression in plants |
03/27/1997 | DE19535321A1 Neues Adhäsin aus Helicobacter pylori Create an adhesin of Helicobacter pylori |
03/27/1997 | CA2658039A1 Human growth hormone variants |
03/27/1997 | CA2232730A1 New adhesin from helicobacter pylori |
03/27/1997 | CA2232500A1 Production and use of type 5 17beta-hydroxysteroid dehydrogenase |
03/27/1997 | CA2232301A1 Pskh-1 ribozymes and uses in disease treatment |
03/27/1997 | CA2231172A1 Nucleic acid delivery vehicle |
03/27/1997 | CA2230479A1 Transcytosis vehicles and enhancers for drug delivery |
03/26/1997 | EP0764721A1 ATP-sensitive potassium-channel proteins and genes for the same |
03/26/1997 | EP0764719A2 Methods for animal cell culture |
03/26/1997 | EP0764213A1 Recombinant aav genome encoding immunodeficiency virus protein |
03/26/1997 | EP0764212A1 Use of anthocyanin genes to maintain male sterile plants |
03/26/1997 | EP0764210A1 Novel bacillus thuringiensis genes coding toxins active against lepidopteran pests |
03/26/1997 | EP0764203A1 Methods for selectively stimulating proliferation of t cells |
03/26/1997 | EP0764171A1 Ligands for induction of antigen specific apoptosis in t cells |
03/26/1997 | EP0764047A1 Polymeric microbeads and method of preparation |
03/26/1997 | EP0764030A1 Use of autoantibodies for tumor therapy and prophylaxis |
03/26/1997 | EP0698096B1 Expression of ntrk1-derived oncogenes in pc12 pheochromocytoma cells and use thereof for the screening of anti-tyrosine kinase compounds |
03/26/1997 | EP0436007B1 Process for the site-directed integration of dna into the genome of plants |
03/26/1997 | CN1146207A Methods of producing effective recombinant serine protease inhibitors and uses of these inhibitors |
03/26/1997 | CN1146156A Means for treating auto-immune diseases and method of treatment |
03/26/1997 | CN1146155A Method for implanting encapsulated cells in a host |
03/26/1997 | CN1146136A Targeted cytolysis of HIV-infected cells by Chimeric CD4 receptor bearing cells |
03/25/1997 | US5614611 Humanized monoclonal antibodies binding to IgE-bearing B cells but not basophils |
03/25/1997 | US5614609 Serine threonine kinase receptor |
03/25/1997 | US5614407 Administering 6-(substituted amino)purine cytokinins |
03/25/1997 | US5614406 Kainate-binding human CNS receptors of the EAA2 family |
03/25/1997 | US5614394 Immunizing mice, fusion of lymphocytes and myeloma cells |
03/25/1997 | US5614393 Production of γ-linolenic acid by a Δ6-desaturase |
03/25/1997 | US5614385 Morphogens |
03/25/1997 | US5614381 Method for the inducible production of proteins in genetically modified eukaryotic host-cells multiplied in vivo |
03/25/1997 | US5614195 Coccidiosis poultry vaccine |
03/25/1997 | US5614191 Antitumor |
03/25/1997 | US5614190 Tissue plasminogen activator having zymogenic or fibrin specific properties |
03/25/1997 | US5614187 Conferring tolerance to foreign tissue in recipient mammal |
03/25/1997 | US5613982 Method of preparing transplant tissue to reduce immunogenicity upon implantation |
03/25/1997 | CA2050479C Cd3 specific recombinant antibody |
03/25/1997 | CA1339014C Antibodies to a4 amyloid peptide |
03/25/1997 | CA1339013C Cross-protective human monoclonal antibody compositions |
03/20/1997 | WO1997010505A1 ANTIBODIES SPECIFIC FOR NATIVE PrP?Sc¿ |
03/20/1997 | WO1997010354A1 ANTIBODY AGAINTS α-CHAIN OF HUMAN INTERLEUKIN 5 RECEPTOR |
03/20/1997 | WO1997010348A1 Methods for inducing selected cell types |
03/20/1997 | WO1997010339A1 Flowering genes |
03/20/1997 | WO1997010336A1 A kinase anchoring protein and uses thereof |
03/20/1997 | WO1997010334A2 Ribozyme therapy for the treatment and/or prevention of restenosis |
03/20/1997 | WO1997010329A1 Neural transplantation using pluripotent neuroepithelial cells |
03/20/1997 | WO1997010328A2 Compositions and method for modulation of gene expression in plants |
03/20/1997 | WO1997010269A1 Immunotherapeutic methods using tumor antigenic peptides coated on cells and vaccines made thereof |
03/20/1997 | WO1997010265A1 Nitrosated hemoglobins and therapeutic uses therefor |
03/20/1997 | WO1997010249A1 Toxoplasma gondii glycoconjugates |
03/20/1997 | WO1997010006A1 Method for inhibiting cell-mediated killing of target cells |
03/20/1997 | WO1997009972A1 Erythrocytes loaded with s-nitrosothiol and uses therefor |
03/20/1997 | WO1997009885A1 Compositions and methods of use of mononuclear phagocytes to promote axonal regeneration |
03/20/1997 | WO1997004114A3 Isolated dna sequence for use as a regulator region in a chimeric gene useful for transforming plants |
03/20/1997 | WO1997004103A3 Mutated 5-enol pyruvylshikimate-3-phosphate synthase, gene coding for said protein and transformed plants containing said gene |
03/20/1997 | WO1997000952A3 A human edg-2 receptor homolog |
03/20/1997 | WO1996025498A3 Mpl ligand analogs |
03/20/1997 | CA2232262A1 Compositions and methods of use of mononuclear phagocytes to promote axonal regeneration |
03/20/1997 | CA2232043A1 Nitrosated hemoglobins and therapeutic uses therefor |
03/20/1997 | CA2232012A1 Toxoplasma gondii glycoconjugates |
03/20/1997 | CA2231804A1 Method for inhibiting cell-mediated killing of target cells |
03/20/1997 | CA2231685A1 Ribozyme therapy for the treatment and/or prevention of restenosis |
03/20/1997 | CA2226728A1 Compositions and method for modulation of gene expression in plants |
03/19/1997 | EP0763543A2 A method for preparing an inflammatory cytokine (MIP-2) and diagnostic and therapeutic applications for the cytokine or its antibody |
03/19/1997 | EP0763124A1 Method for introducing nucleic acid in higher eukaryotic cells |
03/19/1997 | EP0763122A1 Retroviral gene therapy vectors and therapeutic methods based thereon |
03/19/1997 | EP0763120A1 Safe vectors for gene therapy |
03/19/1997 | EP0763118A1 Transgenic plants producing trehalose |
03/19/1997 | EP0763116A1 Recombinant viruses, preparation and use thereof in gene therapy |
03/19/1997 | EP0763109A1 Factor interacting with nuclear proteins |
03/19/1997 | EP0763108A1 Dna sequences |
03/19/1997 | EP0763107A1 Pantropic neurotrophic factors |
03/19/1997 | EP0763106A1 Methods and compositions for treatment of restenosis and cancer using ribozymes |
03/19/1997 | EP0763105A1 Isolated nucleic acid molecule coding for fibroblast activation protein alpha and uses thereof |
03/19/1997 | EP0763104A1 Human dna topoisomerase i-alpha |
03/19/1997 | EP0763103A1 Gene delivery vector using plasmid dna packaged into an adenovirus and a packaging cell line |
03/19/1997 | EP0763102A1 Serum-free medium supplement |
03/19/1997 | EP0763059A1 Recombinant allergen, fragments thereof, corresponding recombinant dna molecules, vectors and hosts containing the dna molecules, diagnostic and therapeutic uses of said allergens and fragments |
03/19/1997 | EP0763058A1 $i(RPS) GENE FAMILY, PRIMERS, PROBES, AND DETECTION METHODS |
03/19/1997 | EP0763057A1 Method for proliferating and differentiating b cells, and uses thereof |
03/19/1997 | EP0763045A1 Haemopoietic maturation factor |
03/19/1997 | EP0762891A1 Immunogenic pharmaceuticals |
03/19/1997 | EP0762889A1 Heparin-binding protein for the treatment of sepsis and processes for its preparation |
03/19/1997 | EP0762885A1 Glial mitogenic factors, their preparation and use |
03/19/1997 | EP0596881B1 Expression in non-tumoral human lymphoblastoid lines with an integrative vector |
03/19/1997 | EP0561965A4 Enhancement of musculature in animals |
03/19/1997 | CN1145640A Method for detection of methylthioadenosine phosphorylase deficiency in mammalian cells |
03/19/1997 | CN1145638A Ribozymes targeting retroviral packaging sequence expression constructs and recombinant retroviruses containing such constructs |